Genpact Limited (NYSE:G) Shares Purchased by Lindbrook Capital LLC

Lindbrook Capital LLC increased its holdings in Genpact Limited (NYSE:GFree Report) by 16.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,020 shares of the business services provider’s stock after purchasing an additional 416 shares during the quarter. Lindbrook Capital LLC’s holdings in Genpact were worth $105,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Johnson Investment Counsel Inc. lifted its stake in Genpact by 0.9% in the 3rd quarter. Johnson Investment Counsel Inc. now owns 47,290 shares of the business services provider’s stock valued at $1,712,000 after buying an additional 400 shares in the last quarter. Suncoast Equity Management boosted its stake in shares of Genpact by 4.1% in the third quarter. Suncoast Equity Management now owns 10,785 shares of the business services provider’s stock worth $390,000 after acquiring an additional 420 shares during the last quarter. HighTower Advisors LLC increased its position in shares of Genpact by 4.5% during the third quarter. HighTower Advisors LLC now owns 10,939 shares of the business services provider’s stock worth $402,000 after purchasing an additional 467 shares in the last quarter. Paralel Advisors LLC raised its stake in Genpact by 1.3% in the 3rd quarter. Paralel Advisors LLC now owns 41,425 shares of the business services provider’s stock valued at $1,500,000 after purchasing an additional 517 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its holdings in Genpact by 0.4% in the 3rd quarter. Treasurer of the State of North Carolina now owns 128,969 shares of the business services provider’s stock valued at $4,669,000 after purchasing an additional 571 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Genpact Stock Up 0.3 %

Shares of NYSE:G opened at $31.76 on Thursday. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of 9.26, a PEG ratio of 1.48 and a beta of 1.07. Genpact Limited has a 12-month low of $29.41 and a 12-month high of $44.63. The business has a 50-day moving average price of $33.27 and a 200 day moving average price of $34.19. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.37.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings results on Thursday, February 8th. The business services provider reported $0.68 earnings per share for the quarter, beating analysts’ consensus estimates of $0.65 by $0.03. The business had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Genpact had a net margin of 14.10% and a return on equity of 23.19%. Sell-side analysts expect that Genpact Limited will post 2.7 EPS for the current year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Monday, March 11th were paid a $0.153 dividend. The ex-dividend date was Friday, March 8th. This is a boost from Genpact’s previous quarterly dividend of $0.14. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.93%. Genpact’s payout ratio is presently 17.78%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on G. StockNews.com lowered shares of Genpact from a “strong-buy” rating to a “buy” rating in a report on Friday, April 5th. Citigroup dropped their price objective on shares of Genpact from $36.00 to $33.00 and set a “neutral” rating for the company in a research note on Monday. JPMorgan Chase & Co. raised their target price on shares of Genpact from $42.00 to $43.00 and gave the stock an “underweight” rating in a research note on Friday, February 9th. Mizuho assumed coverage on Genpact in a research report on Tuesday, January 30th. They issued a “neutral” rating and a $40.00 price target for the company. Finally, Needham & Company LLC reiterated a “buy” rating and set a $40.00 price objective on shares of Genpact in a research report on Friday, February 9th. One analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of “Hold” and an average price target of $39.78.

Read Our Latest Research Report on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.